Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

VRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $36,816,298.16

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$502.45

▲ +8.81 (1.78%)

As of 11/7/2024 01:00 AM ET

Days: 30 | 90 | 365

625,000% Gain

From Crypto Swap Profits | Ad

>> Dive into the Workshop Here

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2024	Jeffrey M. Leiden	Chairman	Sell	3,784	$499.00	$1,888,216.00	9,994
8/30/2024	Sangeeta N Bhatia	Director	Sell	646	$500.00	$323,000.00	4,435
8/7/2024	Carmen Bozic	CMO	Sell	2,280	$476.75	$1,086,990.00	23,259
8/1/2024	Bruce I. Sachs	Director	Sell	5,295	$508.00	$2,689,860.00	40,000
7/24/2024	Carmen Bozic	CMO	Sell	2,280	$488.46	$1,113,688.80	25,539
7/22/2024	Reshma Kewalramani	CEO	Sell	15,202	$497.00	$7,555,394.00	106,172
7/10/2024	Carmen Bozic	CMO	Sell	2,280	$487.34	$1,111,135.20	27,819
6/26/2024	Carmen Bozic	CMO	Sell	2,280	$471.72	$1,075,521.60	30,099
6/12/2024	Carmen Bozic	CMO	Sell	2,280	$478.00	$1,089,840.00	32,379
6/12/2024	E. Morrey Atkinson, III	EVP	Sell	7,288	$478.00	$3,483,664.00	15,972
5/30/2024	Ourania Tatsis	EVP	Sell	2,350	$439.11	$1,031,908.50	53,523
5/29/2024	Carmen Bozic	CMO	Sell	2,280	$445.56	$1,015,876.80	34,659
5/28/2024	Charles F. Wagner, Jr.	CFO	Sell	3,250	$454.79	$1,478,067.50	50,387
5/24/2024	Reshma Kewalramani	CEO	Sell	1,565	$457.00	$715,205.00	121,374
5/22/2024	Bruce I. Sachs	Director	Sell	7,073	$448.00	$3,168,704.00	40,000
2/26/2024	Ourania Tatsis	EVP	Sell	354	$425.70	$150,697.80	55,804
2/20/2024	Ourania Tatsis	EVP	Sell	480	$420.79	$201,979.20	59,827
2/12/2024	Amit Sachdev	EVP	Sell	3,222	$420.24	$1,354,013.28	74,364
2/12/2024	Jeffrey M. Leiden	Chairman	Sell	2,656	$419.51	$1,114,218.56	27,644
2/12/2024	Kristen Ambrose	CAO	Sell	1,374	$420.24	$577,409.76	9,676
2/12/2024	Stuart A. Arbuckle	COO	Sell	4,295	$420.24	$1,804,930.80	75,718
1/8/2024	Jeffrey M. Leiden	Chairman	Sell	6,648	$419.07	$2,785,977.36	2,423
11/6/2023	Bruce I. Sachs	Director	Sell	11,250	$385.00	$4,331,250.00	40,000
10/31/2023	Carmen Bozic	CMO	Sell	5,651	$355.92	$2,011,303.92	34,952
10/17/2023	Carmen Bozic	CMO	Sell	5,651	$373.25	$2,109,235.75	40,603
10/17/2023	Sangeeta N Bhatia	Director	Sell	243	$375.00	$91,125.00	3,901
10/16/2023	Jeffrey M. Leiden	Chairman	Sell	12,962	$374.00	$4,847,788.00	22,425
10/6/2023	Sangeeta N Bhatia	Director	Sell	242	$360.00	$87,120.00	4,144
10/3/2023	Carmen Bozic	CMO	Sell	5,651	$345.28	$1,951,177.28	46,254
10/2/2023	Jonathan Biller	EVP	Sell	610	$346.76	$211,523.60	10,569
9/19/2023	Carmen Bozic	CMO	Sell	5,651	$351.00	$1,983,501.00	51,905
8/23/2023	Ourania Tatsis	EVP	Sell	2,500	$355.00	$887,500.00	48,637
8/9/2023	David Altshuler	EVP	Sell	63	$345.51	$21,767.13	32,038
8/9/2023	Sangeeta N Bhatia	Director	Sell	242	$345.51	$83,613.42	4,386
7/17/2023	Bruce I. Sachs	Director	Sell	11,250	$356.75	$4,013,437.50	40,000
7/17/2023	Reshma Kewalramani	CEO	Sell	7,828	$355.00	$2,778,940.00	118,906
6/15/2023	Stuart A. Arbuckle	COO	Sell	8,603	$349.00	$3,002,447.00	56,556
5/30/2023	Kristen Ambrose	CAO	Sell	289	$329.82	$95,317.98	6,838
5/30/2023	Stuart A. Arbuckle	COO	Sell	82	$329.82	$27,045.24	56,556
5/8/2023	Bastiano Sanna	EVP	Sell	2,850	$350.00	$997,500.00	32,038
5/8/2023	Jeffrey M. Leiden	Chairman	Sell	1,125	$349.00	$392,625.00	35,387
5/5/2023	Bastiano Sanna	EVP	Sell	422	$350.03	$147,712.66	34,888
5/5/2023	Jeffrey M. Leiden	Chairman	Sell	879	$349.56	$307,263.24	36,512
5/2/2023	Bastiano Sanna	EVP	Sell	1,622	$350.66	$568,770.52	38,091
5/2/2023	Jeffrey M. Leiden	Chairman	Sell	6,450	$349.89	$2,256,790.50	41,899
5/2/2023	Sangeeta N Bhatia	Director	Sell	580	$348.28	$202,002.40	4,628
4/27/2023	Reshma Kewalramani	CEO	Sell	3,317	$339.08	$1,124,728.36	126,652
4/12/2023	Bastiano Sanna	EVP	Sell	7,567	$326.70	$2,472,138.90	39,713
4/12/2023	Bruce I. Sachs	Director	Sell	21,300	$326.73	$6,959,349.00	41,210
4/4/2023	Bastiano Sanna	EVP	Sell	522	$315.81	$164,852.82	47,280
3/24/2023	Charles F. Wagner, Jr.	CFO	Sell	1,768	$305.38	$539,911.84	49,611
3/17/2023	Charles F. Wagner, Jr.	CFO	Sell	2,000	$296.39	$592,780.00	51,379
3/16/2023	Bastiano Sanna	EVP	Sell	2,746	$300.59	$825,420.14	49,268
3/13/2023	Charles F. Wagner, Jr.	CFO	Sell	2,666	$293.83	$783,350.78	53,379
3/10/2023	Charles F. Wagner, Jr.	CFO	Sell	2,088	$289.61	$604,705.68	56,045
2/27/2023	Kristen Ambrose	CAO	Sell	1,207	$287.55	$347,072.85	7,303
2/27/2023	Ourania Tatsis	EVP	Sell	354	$287.48	$101,767.92	56,805
2/27/2023	Stuart A. Arbuckle	COO	Sell	5,034	$287.47	$1,447,123.98	56,556
2/22/2023	Stuart A. Arbuckle	COO	Sell	2,401	$294.33	$706,686.33	66,304
2/13/2023	Ourania Tatsis	EVP	Sell	275	$298.99	$82,222.25	65,765
2/13/2023	Stuart A. Arbuckle	COO	Sell	4,887	$298.92	$1,460,822.04	82,003
2/6/2023	David Altshuler	EVP	Sell	1,304	$306.00	$399,024.00	68,645
1/30/2023	Lloyd Carney	Director	Sell	2,700	$320.52	$865,404.00	4,150
1/27/2023	Yuchun Lee	Director	Sell	1,429	$322.03	$460,180.87	1,875
1/25/2023	Reshma Kewalramani	CEO	Sell	10,000	$315.05	$3,150,500.00	89,598
1/25/2023	Yuchun Lee	Director	Sell	4,000	$313.96	$1,255,840.00	1,875
1/23/2023	Yuchun Lee	Director	Sell	2,129	$312.02	$664,290.58	1,875
1/18/2023	Yuchun Lee	Director	Sell	442	$312.17	$137,979.14	1,875
11/7/2022	David Altshuler	EVP	Sell	1,303	$303.04	$394,861.12	36,077
10/24/2022	Sangeeta N Bhatia	Director	Sell	621	$310.00	$192,510.00	4,040
10/18/2022	Bastiano Sanna	EVP	Sell	1,791	$300.31	$537,855.21	39,192
8/15/2022	Joy Liu	SVP	Sell	3,747	$303.90	$1,138,713.30	9,605
8/15/2022	Reshma Kewalramani	CEO	Sell	11,689	$305.06	$3,565,846.34	99,598
8/15/2022	Stuart A. Arbuckle	COO	Sell	22,173	$303.93	$6,739,039.89	45,278
8/9/2022	Joy Liu	SVP	Sell	946	$300.00	$283,800.00	13,388
8/9/2022	Ourania Tatsis	EVP	Sell	1,400	$298.97	$418,558.00	46,090
8/9/2022	Stuart A. Arbuckle	COO	Sell	5,690	$300.67	$1,710,812.30	60,996
8/8/2022	Sangeeta N Bhatia	Director	Sell	621	$293.03	$181,971.63	4,661
7/29/2022	Sangeeta N Bhatia	Director	Sell	621	$278.77	$173,116.17	5,282
7/25/2022	Jeffrey M. Leiden	Chairman	Sell	132,079	$281.38	$37,164,389.02	2,423
7/19/2022	David Altshuler	EVP	Sell	17,865	$288.65	$5,156,732.25	36,077
6/24/2022	Reshma Kewalramani	CEO	Sell	11,689	$291.30	$3,405,005.70	111,153
5/4/2022	Bastiano Sanna	EVP	Sell	36	$275.09	$9,903.24	41,660
5/2/2022	Bastiano Sanna	EVP	Sell	320	$259.16	$82,931.20	41,696
5/2/2022	Charles F. Wagner, Jr.	CFO	Sell	343	$258.83	$88,778.69	42,730
5/2/2022	Sangeeta N Bhatia	Director	Sell	737	$258.94	$190,838.78	5,903
5/2/2022	Stuart A. Arbuckle	COO	Sell	306	$263.98	$80,777.88	64,760
4/29/2022	Joy Liu	SVP	Sell	120	$275.41	$33,049.20	14,334
4/25/2022	Kristen Ambrose	CAO	Sell	327	$269.55	$88,142.85	3,496
4/18/2022	Yuchun Lee	Director	Sell	2,000	$284.23	$568,460.00	1,875
4/13/2022	Jeffrey M. Leiden	Chairman	Sell	15,789	$289.04	$4,563,652.56	74,160
4/13/2022	Yuchun Lee	Director	Sell	2,000	$287.50	$575,000.00	1,875
4/11/2022	Yuchun Lee	Director	Sell	2,000	$280.30	$560,600.00	1,875
4/7/2022	Bastiano Sanna	EVP	Sell	561	$276.18	$154,936.98	42,782
4/7/2022	Yuchun Lee	Director	Sell	2,000	$274.86	$549,720.00	1,099
4/4/2022	Bastiano Sanna	EVP	Sell	562	$267.71	$150,453.02	43,343
4/4/2022	Yuchun Lee	Director	Sell	2,000	$267.72	$535,440.00	1,875
4/1/2022	Charles F. Wagner, Jr.	CFO	Sell	2,582	$264.76	$683,610.32	43,620
3/31/2022	Margaret G. McGlynn	Director	Sell	5,000	$262.27	$1,311,350.00	1,099
3/17/2022	Charles F. Wagner, Jr.	CFO	Sell	3,171	$250.15	$793,225.65
3/17/2022	Ourania Tatsis	EVP	Sell	2,833	$250.11	$708,561.63
2/25/2022	Ourania Tatsis	EVP	Sell	325	$230.95	$75,058.75
2/18/2022	Ourania Tatsis	EVP	Sell	519	$231.00	$119,889.00
2/11/2022	David Altshuler	EVP	Sell	2,297	$235.02	$539,840.94
2/2/2022	Bastiano Sanna	EVP	Sell	1,040	$250.98	$261,019.20
2/2/2022	Charles F. Wagner, Jr.	CFO	Sell	2,944	$250.07	$736,206.08
1/28/2022	Margaret G. McGlynn	Director	Sell	5,000	$241.79	$1,208,950.00
11/15/2021	Amit Sachdev	EVP	Sell	51	$187.19	$9,546.69
11/15/2021	Stuart A. Arbuckle	COO	Sell	3	$187.26	$561.78

The Crypto That’s Making Wall Street Sweat

From Crypto 101 Media | Ad

The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.

Click here to discover our #1 crypto for the market right now – poised for massive growth

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

90.96% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/8/2024	W.G. Shaheen & Associates DBA Whitney & Co	43,406	$20.19M	2.2%	-15.1%	0.017%
11/8/2024	Princeton Capital Management LLC	15,110	$7.03M	2.2%	+0.5%	0.006%
11/8/2024	Fifth Third Wealth Advisors LLC	997	$0.46M	0.0%	+96.3%	0.000%
11/8/2024	Wrapmanager Inc.	2,293	$1.07M	0.3%	-18.3%	0.001%
11/7/2024	Prospera Financial Services Inc	13,498	$6.28M	0.2%	+430.0%	0.005%
11/7/2024	Whalen Wealth Management Inc.	1,424	$0.66M	0.5%	N/A	0.001%
11/7/2024	Knuff & Co LLC	14,193	$6.60M	2.0%	-1.0%	0.005%
11/7/2024	Caprock Group LLC	38,088	$17.71M	0.6%	+0.4%	0.015%
11/7/2024	Pathstone Holdings LLC	40,653	$18.91M	0.1%	+5.5%	0.016%
11/7/2024	Aviance Capital Partners LLC	830	$0.39M	0.1%	+21.9%	0.000%
11/7/2024	First Turn Management LLC	35,222	$16.38M	2.6%	-30.5%	0.014%
11/7/2024	Joseph Group Capital Management	5,672	$2.64M	1.0%	+17.7%	0.002%
11/7/2024	Meeder Advisory Services Inc.	5,634	$2.62M	0.2%	+1.1%	0.002%
11/7/2024	WP Advisors LLC	3,199	$1.49M	0.5%	-20.9%	0.001%
11/7/2024	Braun Stacey Associates Inc.	51,497	$23.95M	0.9%	-9.4%	0.020%
11/7/2024	GLOBALT Investments LLC GA	7,925	$3.69M	0.1%	-2.0%	0.003%
11/7/2024	Quest Partners LLC	3,284	$1.53M	0.1%	+3,856.6%	0.001%
11/7/2024	MAI Capital Management	2,418	$1.13M	0.0%	-33.5%	0.001%
11/7/2024	Prudent Man Advisors LLC	1,884	$0.88M	0.3%	-6.2%	0.001%
11/7/2024	Swiss National Bank	766,000	$356.25M	0.2%	+0.2%	0.297%
11/7/2024	Thrivent Financial for Lutherans	91,675	$42.64M	0.1%	-3.3%	0.036%
11/7/2024	Claro Advisors LLC	2,425	$1.13M	0.1%	+24.1%	0.001%
11/7/2024	Concord Asset Management LLC VA	2,827	$1.32M	0.3%	+21.6%	0.001%
11/6/2024	Adero Partners LLC	1,342	$0.62M	0.0%	+2.2%	0.001%
11/6/2024	Atlanta Consulting Group Advisors LLC	1,769	$0.82M	0.2%	+303.9%	0.001%
11/6/2024	Mutual of America Capital Management LLC	33,832	$15.74M	0.2%	-2.2%	0.013%
11/6/2024	Natixis Advisors LLC	461,886	$214.81M	0.4%	+5.8%	0.179%
11/6/2024	Mizuho Securities USA LLC	77,393	$35.99M	0.1%	+289.0%	0.030%
11/6/2024	Kentucky Retirement Systems Insurance Trust Fund	7,642	$3.55M	0.2%	-8.2%	0.003%
11/6/2024	Kentucky Retirement Systems	17,981	$8.36M	0.2%	-7.5%	0.007%
11/6/2024	Ipswich Investment Management Co. Inc.	1,523	$0.71M	0.2%	+2.7%	0.001%
11/6/2024	Coastline Trust Co	6,579	$3.06M	0.4%	+13.1%	0.003%
11/6/2024	Valley Wealth Managers Inc.	50,474	$23.47M	1.7%	-2.0%	0.020%
11/6/2024	Empowered Funds LLC	12,605	$5.86M	0.1%	-58.1%	0.005%
11/6/2024	Empirical Finance LLC	8,916	$4.15M	0.2%	+2.2%	0.003%
11/6/2024	Sheaff Brock Investment Advisors LLC	1,109	$0.52M	0.0%	-9.0%	0.000%
11/6/2024	CIBC Asset Management Inc	80,102	$37.25M	0.1%	+5.9%	0.031%
11/6/2024	Broderick Brian C	11,460	$5.33M	1.0%	+51.1%	0.004%
11/6/2024	OneDigital Investment Advisors LLC	2,817	$1.31M	0.0%	+62.7%	0.001%
11/6/2024	Impax Asset Management Group plc	7,433	$3.46M	0.0%	-86.1%	0.003%
11/6/2024	ING Groep NV	53,538	$24.90M	0.1%	-19.0%	0.021%
11/6/2024	Lifeworks Advisors LLC	11,853	$5.51M	1.1%	-4.5%	0.005%
11/6/2024	Tokio Marine Asset Management Co. Ltd.	7,681	$3.57M	0.2%	+8.0%	0.003%
11/6/2024	Sivik Global Healthcare LLC	10,000	$4.65M	2.0%	-33.3%	0.004%
11/6/2024	Metis Global Partners LLC	13,455	$6.26M	0.2%	+8.1%	0.005%
11/6/2024	Curi RMB Capital LLC	1,580	$0.74M	0.0%	+4.7%	0.001%
11/6/2024	Aubrey Capital Management Ltd	6,900	$3.21M	1.2%	N/A	0.003%
11/6/2024	Zions Bancorporation N.A.	171	$80K	0.0%	-20.8%	0.000%
11/6/2024	KBC Group NV	96,727	$44.99M	0.1%	+11.1%	0.037%
11/6/2024	Huntington National Bank	39,229	$18.25M	0.1%	-2.8%	0.015%
11/6/2024	ICICI Prudential Asset Management Co Ltd	3,369	$1.57M	0.2%	+18.9%	0.001%
11/6/2024	Kovack Advisors Inc.	1,257	$0.59M	0.1%	+3.7%	0.000%
11/6/2024	Arjuna Capital	5,473	$2.55M	0.7%	-8.9%	0.002%
11/6/2024	Oppenheimer & Co. Inc.	13,128	$6.11M	0.1%	-4.4%	0.005%
11/6/2024	Oppenheimer Asset Management Inc.	23,390	$10.88M	0.1%	-4.0%	0.009%
11/6/2024	Cornerstone Planning Group LLC	58	$27K	0.0%	-26.6%	0.000%
11/6/2024	Pinnacle Financial Partners Inc	6,641	$3.09M	0.1%	+985.1%	0.003%
11/5/2024	MQS Management LLC	1,358	$0.63M	0.4%	+4.8%	0.001%
11/5/2024	Chase Investment Counsel Corp	7,063	$3.28M	1.1%	-14.4%	0.003%
11/5/2024	Souders Financial Advisors	1,466	$0.68M	0.1%	+2.1%	0.001%
11/5/2024	Future Fund LLC	1,702	$0.80M	2.4%	-22.1%	0.001%
11/5/2024	Victory Capital Management Inc.	310,414	$144.37M	0.1%	-4.7%	0.120%
11/5/2024	Aptus Capital Advisors LLC	18,716	$8.70M	0.1%	+19.6%	0.007%
11/5/2024	Cumberland Partners Ltd	43,200	$20.09M	1.4%	+50.7%	0.017%
11/5/2024	Prime Capital Investment Advisors LLC	3,456	$1.61M	0.0%	+2.3%	0.001%
11/5/2024	Hemenway Trust Co LLC	40,119	$18.66M	1.5%	+41.1%	0.016%
11/5/2024	Ashton Thomas Private Wealth LLC	2,291	$1.07M	0.1%	-2.1%	0.001%
11/5/2024	Platform Technology Partners	1,266	$0.59M	0.2%	-6.6%	0.000%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	672,098	$312.58M	0.2%	+1.0%	0.260%
11/5/2024	Baillie Gifford & Co.	140,580	$65.38M	0.0%	-16.1%	0.054%
11/5/2024	Bronte Capital Management Pty Ltd.	19,856	$9.24M	0.8%	+0.2%	0.008%
11/5/2024	WealthPlan Investment Management LLC	1,366	$0.64M	0.1%	N/A	0.001%
11/5/2024	Apollon Wealth Management LLC	8,196	$3.81M	0.1%	+10.7%	0.003%
11/5/2024	Nations Financial Group Inc. IA ADV	3,981	$1.85M	0.1%	+6.0%	0.002%
11/4/2024	Laffer Tengler Investments Inc.	2,874	$1.34M	0.3%	+2.9%	0.001%
11/4/2024	Venturi Wealth Management LLC	2,532	$1.18M	0.1%	+1.6%	0.001%
11/4/2024	Ashton Thomas Securities LLC	3,189	$1.48M	0.3%	+6.3%	0.001%
11/4/2024	Los Angeles Capital Management LLC	18,727	$8.71M	0.0%	-71.1%	0.007%
11/4/2024	Meritage Portfolio Management	36,512	$16.98M	1.0%	-1.6%	0.014%
11/4/2024	Crossmark Global Holdings Inc.	5,866	$2.73M	0.0%	-4.8%	0.002%
11/4/2024	Mayflower Financial Advisors LLC	1,482	$0.69M	0.1%	-99.8%	0.001%
11/4/2024	Legacy Capital Wealth Partners LLC	1,087	$0.51M	0.1%	+85.5%	0.000%
11/4/2024	Axxcess Wealth Management LLC	2,850	$1.33M	0.0%	+16.6%	0.001%
11/4/2024	Guerra Pan Advisors LLC	603	$0.28M	0.2%	+6.9%	0.000%
11/4/2024	Sigma Planning Corp	2,746	$1.28M	0.0%	-8.7%	0.001%
11/4/2024	Arrow Financial Corp	5,595	$2.60M	0.2%	-6.8%	0.002%
11/2/2024	Transcendent Capital Group LLC	224	$0.10M	0.1%	-69.7%	0.000%
11/2/2024	Covestor Ltd	684	$0.32M	0.2%	-3.1%	0.000%
11/1/2024	Proficio Capital Partners LLC	667	$0.31M	0.0%	-21.2%	0.000%
11/1/2024	Atria Investments Inc	20,125	$9.36M	0.1%	-7.2%	0.008%
11/1/2024	Essex Savings Bank	677	$0.32M	0.1%	+12.5%	0.000%
11/1/2024	Objective Capital Management LLC	546	$0.25M	0.1%	N/A	0.000%
11/1/2024	Lindbrook Capital LLC	29,632	$13.78M	1.2%	+36.2%	0.011%
11/1/2024	Assetmark Inc.	204,071	$94.91M	0.3%	-46.3%	0.079%
11/1/2024	Galvin Gaustad & Stein LLC	21,961	$10.21M	0.9%	-40.1%	0.009%
11/1/2024	SpiderRock Advisors LLC	2,898	$1.35M	0.0%	+57.2%	0.001%
11/1/2024	Equitable Trust Co.	524	$0.24M	0.0%	N/A	0.000%
11/1/2024	CWA Asset Management Group LLC	6,307	$2.93M	0.2%	N/A	0.002%
11/1/2024	Leavell Investment Management Inc.	5,509	$2.56M	0.1%	+16.7%	0.002%
11/1/2024	Fiera Capital Corp	6,154	$2.86M	0.0%	-31.6%	0.002%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $502.45

$488.06

$504.31

50 Day Range

MA: $474.81

$448.60

$499.88

52 Week Range

Now: $502.45

$341.90

$510.64

Volume

992,276 shs

Average Volume

1,105,095 shs

Market Capitalization

$129.40 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.39

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top insider shareholders include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Edward Morrow Atkinson III (EVP)
Jonathan Biller (EVP)
Kristen Ambrose (CAO)
Sangeeta N Bhatia (Director)
Lloyd Carney (Director)
Yuchun Lee (Director)
Learn More about top insider investors at Vertex Pharmaceuticals.
Who are the major institutional investors of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top institutional investors include:
Swiss National Bank — 0.30%
Sumitomo Mitsui Trust Group Inc. — 0.26%
Swedbank AB — 0.22%
National Pension Service — 0.20%
DekaBank Deutsche Girozentrale — 0.20%
Natixis Advisors LLC — 0.18%
Learn More about top institutional investors of Vertex Pharmaceuticals stock.
Which major investors are selling Vertex Pharmaceuticals stock?: Within the previous quarter, VRTX stock was sold by these institutional investors:
Mayflower Financial Advisors LLC
AMF Tjanstepension AB
Assetmark Inc.
Swedbank AB
Robeco Institutional Asset Management B.V.
Los Angeles Capital Management LLC
Impax Asset Management Group plc
Impax Asset Management Group plc
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Edward Morrow Atkinson III (EVP)
Learn More investors selling Vertex Pharmaceuticals stock.
Which major investors are buying Vertex Pharmaceuticals stock?: During the previous quarter, VRTX stock was acquired by institutional investors including:
International Assets Investment Management LLC
AustralianSuper Pty Ltd
Assenagon Asset Management S.A.
Mizuho Securities USA LLC
National Pension Service
Allspring Global Investments Holdings LLC
Adams Diversified Equity Fund Inc.
Natixis Advisors LLC